Skip to main content
Caplight Logo









TECLens, Inc.

TECLens, Inc.

Private
Stamford, ConnecticutHealthcare & Life Scienceshttps://teclens.com

Last Round

Seed Round

Jul 9, 2026

Total Funding Raised

$9.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TECLens, Inc. operates in Healthcare & Life Sciences and is based in Stamford, Connecticut. Its latest recorded funding round was a Series A round in February 2025.

TECLens, Inc. is a medical device company developing a non-invasive, personalized corneal cross-linking technology for vision correction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Hardware + Subscription

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TECLens, Inc. Comparables

Compare TECLens, Inc. with similar companies based on industry and business-model similarity.

TECLens, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EMAGine AG
81%
Clerio Vision
81%
Ace Vision Group
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TECLens, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 9, 2026
Series AFeb 11, 2025
Early FundingFeb 1, 2019
Early FundingMay 22, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Thomas Dunlap

Chief Executive Officer

Executive Team

Rob Hughes

CFO

Executive Team

Patrick Lopath

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

TECLens, Inc. Investors

Notable investors and investment history

TECLens, Inc. investors
InvestorRounds
Yonjin CapitalSeries A
RimonciSeries A
Johnson & Johnson Innovation - JJDC, Inc.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Open roles increased to 13, 108% of headcount.

  • Jul 27, 2026

    Monthly visitors increased 38% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingAug 25, 2026

    TECLens, Inc. closes a $10M Series A2 extension financing from existing investors, including Johnson & Johnson Innovation - JJDC, Inc., on Aug 25th '26 in Connecticut to advance its proof-of-concept study and expand its first-in-human program for non-invasive vision correction.

  • is_developingAug 24, 2026

    TECLens, Inc. is testing a new approach to presbyopia in Connecticut after raising $5.2 million to advance its clinical development on Aug 24th '26.

  • receives_financingAug 24, 2026

    TECLens, Inc. raises $5.2M to advance its clinical development and tests a new approach to presbyopia in Connecticut on Aug 24th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

TECLens, Inc. Filings

Explore SEC and related filing metadata, where available.

TECLens, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TECLens, Inc.'s valuation, stock price, and market status.

Is TECLens, Inc. a public or private company?

TECLens, Inc. is a private company.

What is the current stock price of TECLens, Inc.?

TECLens, Inc. is a private company, so its shares have no public market price. Caplight tracks TECLens, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TECLens, Inc. worth (valuation)?

Valuation information for TECLens, Inc. is not publicly available.

Can I buy TECLens, Inc. stock?

TECLens, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TECLens, Inc.'s last funding round?

TECLens, Inc.'s most recent funding round was Seed Round on July 9, 2026.

Who are the main investors in TECLens, Inc.?

Key investors in TECLens, Inc. include Yonjin Capital, Johnson & Johnson Innovation - JJDC, Inc..

Will TECLens, Inc. IPO soon?

No public IPO plans have been announced for TECLens, Inc..

How can I track TECLens, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in TECLens, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersStamford, Connecticut
Employee Range11
Year Founded2013
Last FundingJul 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?